Treatment of delirium in early postoperative cardiosurgical patients. Article
ISSN (print) 1726-9806     ISSN (online) 1818-474X
#2019-3
PDF_2019-3_77-83 (Russian)
HTML_2019-3_77-83 (Russian)

Keywords

cardiosurgery
postoperative period
delirium
sedation
dexmedetomidine

How to Cite

1.
Rubinchik V.E., Kasherininov I.Y., Bautin A.E., Mazurok V.A. Treatment of delirium in early postoperative cardiosurgical patients. Article. Annals of Critical Care. 2019;(3):77-83. doi:10.21320/1818-474X-2019-3-77-83

Statistic

Abstract Views: 108
PDF_2019-3_77-83 (Russian) Downloads: 28
HTML_2019-3_77-83 (Russian) Downloads: 12
Statistic from 01.07.2024

Language

English Русский

Social Networks

Abstract

Background. Postoperative delirium is highly relevant in elderly patients who undergo cardiosurgical interventions with cardiopulmonary bypass (CPB), long stay in intensive care unit (ICU), suffering from widespread atherosclerosis and having a wide range of comorbidities.

In the world literature there is a lot of data on the successful use of dexmedetomidine for sedation, prevention and relief of delirium, including patients after open-heart interventions. Comparative evaluation of dexmedetomidine and neuroleptic sedation with “traditional” for Russian Federation management of cardiosurgical patients suffering from postoperative delirium seems to be a relevant clinical and research task.

Objectives. Comparative evaluation of the effectiveness of drug sedation with dexmedetomidine and propofol in cardiosurgical patients with postoperative delirium.

Material and Methods. An open prospective cohort study took place in 2017–2019 and included 42 patients who underwent open-heart intervention with CPB and had delirium in the postoperative period.

Exclusion criteria: severe brachiocephal artery atherosclerosis, acute period or consequences of stroke, signs of acute respiratory failure associated with the pathology of the respiratory system, severe cardiovascular failure, age over 80 years.

Detection and treatment of delirium were performed by an intensivist together with a psychiatrist. Haloperidol was used as the main antipsychotic. Depending on the drug used for medical sedation, the patients were divided into 2 groups: 22 patients underwent medical sedation with propofol, 20 with dexmedetomidine in the form of an extended infusion. According to the results of the study, the length of patients’ stay in the ICU and hospital, the need for vasopressor therapy, mechnical ventilation (MV), and the duration of delirium were analyzed.

Results. In patients of the dexmedetomidine group, compared with the propofol group, the following was observed: less need for vasopressors and the duration of their use, less frequent use of MV (27.2 % versus 10.0 % of cases, p < 0.05), shorter stay in ICU (4.4 ± 1.8 vs 7.2 ± 2.3 days, p < 0.05), and finally, more rapid relief of the delirium itself (34.7 ± 6.8 vs 52.6 ± 8.9 hours, p < 0.05). There was no statistically significant difference between the groups for the length of hospital stay.

Conclusions. In the early postoperative period of open-heart interventions, medical sedation using dexmedetomidine as a component of the delirium therapy seems to be preferable to propofol sedation. Using of dexmedetomidine during study was associated with more rapid relief of the delirium, more favorable hemodynamic profile, less need for MV and duration of MV, as well as shorter duration of stay in the ICU, compared with the use of propofol sedation, which allows us to recommend routine use of dexmedetomidine in the cardiosurgical ICU.

PDF_2019-3_77-83 (Russian)
HTML_2019-3_77-83 (Russian)

References

  1. McKhann G.M., Grega M.A., Borowicz L.M.Jr., et al. Stroke and encephalopathy after cardiac surgery: an update. Stroke. 2006; 37: 562–571. DOI: 10.1161/01.STR.0000199032.78782.6c
  2. Newman M.F., Grocott H.P., Mathew J.P., et al. Report of the substudy assessing the impact of neurocognitive function on quality of life 5 years after cardiac surgery. Stroke. 2001; 32: 2874–2881.
  3. Selnes O.A., Goldsborough M.A., Borowicz L.M.Jr., et al. Determinants of cognitive change after coronary artery bypass surgery: a multifactorial problem. Ann. Thorac. Surg. 1999; 67: 1669–1676.
  4. Maagaard M., Barbateskovic M., Perner A., et al. Dexmedetomidine for the prevention of delirium in critically ill patients — a protocol for a systematic review. Acta Anaesthesiol. Scand. 2019; 63(4): 540–548. DOI: 10.1111/aas.13313
  5. Collet M.O., Caballero J., Sonneville R., et al. Prevalence and risk factors related to haloperidol use for delirium in adult intensive care patients: the multinational AID-ICU inception cohort study. Intensive Care Med. 2018; 44(7): 1081–1089. DOI: 10.1007/s00134-018-5204-y
  6. Allen J., Alexander E. Prevention, recognition, and management of delirium in the intensive care unit. AACN Adv. Crit. Care. 2012; 23(1): 5–11; quiz 2–3. DOI: 10.1097/NCI.0b013e31822c3633
  7. Zaal I.J., Slooter A.J. Delirium in critically ill patients: epidemiology, pathophysiology, diagnosis and management. Drugs. 2012; 72(11): 1457–1471. DOI: 10.2165/11635520-000000000-00000
  8. Kalabalik J., Brunetti L., El-Srougy R. Intensive care unit delirium: a review of the literature. J. Pharm. Pract. 2014; 27(2): 195–207. DOI: 10.1177/ 0897190013513804
  9. Jackson P., Khan A. Delirium in critically ill patients. Crit. Care Clin. 2015; 31(3): 589–603. DOI: 10.1016/j.ccc.2015.03.011
  10. Pandharipande P., Cotton B.A., Shintani A., et al. Prevalence and risk factors for development of delirium in surgical and trauma intensive care unit patients. J. Trauma. 2008; 65(1): 34–41. DOI: 10.1097/TA.0b013e31814b2c4d
  11. Mantz J., Josserand J., Hamada S. Dexmedetomidine: new insights. Eur. J. Anaesthesiol. 2011; 28(1): 3–6. DOI: 10.1097/EJA.0b013e32833e266d
  12. Gerlach A.T., Dasta J.F. Dexmedetomidine: an updated review. Ann. Pharmacother. 2007; 41: 245–254. DOI: 10.1345/aph.1H314
  13. Honey B.L., Benefield R.J., Miller J.L., Johnson P.N. a2-receptor agonists for treatment and prevention of iatrogenic opioid abstinence syndrome in critically ill patients. Ann Pharmacother. 2009; 43: 1506–1511. DOI: 10.1345/aph.1M161
  14. Anger K.E. Dexmedetomidine: a review of its use for the management of pain, agitation, and delirium in the intensive care unit. Curr. Pharm. Des. 2013; 19: 4003–4013. DOI: 10.2174/1381612811319220009
  15. Gerlach A.T., Murphy C.V., Dasta J.F. An updated focused review of dexmedetomidine in adults. Ann. Pharmacother. 2009; 43(12): 2064–2074. DOI: 10.1345/aph.1M310
  16. Keating G.M. Dexmedetomidine: a review of its use for sedation in the intensive care setting. Drugs. 2015; 75(10): 1119–1130. DOI: 10.1007/s40265-015-0419-5
  17. Man Y., Guo Z., Cao J., Mi W. Efficacy of perioperative dexmedetomidine in postoperative neurocognitive function: a meta-analysis. Clin. Exp. Pharmacol. Physiol. 2015; 42(8): 837–842. DOI: 10.1111/1440–1681.12432
  18. Nguyen J., Nacpil N. Effectiveness of dexmedetomidine versus propofol on extubation times, length of stay and mortality rates in adult cardiac surgery patients: a systematic review and meta-analysis. JBI Database System. Rev. Implement. Rep. 2018; 16(5): 1220–1239. DOI: 10.11124/JBISRIR-2017-003488
  19. Peng K., Zhang J., Meng X.W., et al. Optimization of postoperative intravenous patient-controlled analgesia with opioid-dexmedetomidine combinations: an updated meta-analysis with trial sequential analysis of randomized controlled trials. Pain Physician. 2017; 20(7): 569–596.
  20. Zhou C., Zhu Y., Liu Z., Ruan L. Effect of dexmedetomidine on postoperative cognitive dysfunction in elderly patients after general anaesthesia: a meta-analysis. J. Int. Med. Res. 2016; 44(6): 1182–1190. DOI: 10.1177/ 0300060516671623
  21. Liu X., Xie G., Zhang K., et al. Dexmedetomidine vs propofol sedation reduces delirium in patients after cardiac surgery: a meta-analysis with trial sequential analysis of randomized controlled trials. J. Crit. Care. 2017; 38: 190–196. DOI: 10.1016/j.jcrc.2016.10.026
  22. Еременко А.А., Чернова Е.В. Применение дексмедетомидина для внутривенной седации и лечения делирия в раннем послеоперационном периоде у кардиохирургических больных. Анестезиология и реаниматология. 2013; 5: 4–8. [Eremenko A.A., Chernova E.V. Dexomedetomidine use for intravenous sedation and delirium treatment during early postoperative period in cardio-surgical patients. Anesteziologia i reanimatologia. 2013; 5: 4–8. (In Russ)]
  23. Еременко А.А., Чернова Е.В. Лечение делирия в раннем послеоперационном периоде у кардиохирургических пациентов. Анестезиология и реаниматология. 2014; 3: 30–34. [Eremenko A.A., Chernova E.V. Treatment of delirium in cardio-surgical patients in early postoperative period. Anesteziologia i reanimatologia. 2014; 3: 30–34. (In Russ)]
  24. Еременко А.А., Чернова Е.В. Сравнение дексмедетомидина и пропофола при внутривенной седации в раннем послеоперационном периоде у кардиохирургических пациентов. Анестезиология и реаниматология. 2014; 2: 37–41. [Eremenko A.A., Chernova E.V. Comparison of dexmedetomidine and propofol for short-term sedation in early postoperative period after cardiac surgery. Anesteziologia i reanimatologia. 2014; 2: 37–41. (In Russ)]
  25. Никода В.В., Грицан А.И., Еременко А.А., et al. Эффективность и безопасность применения дексмедетомидина для седации больных при проведении продленной ИВЛ в отделениях реанимации и интенсивной терапии (результаты российского многоуровневого исследования). Анестезиология и реаниматология. 2015; 60(5): 47–53.[Nikoda V.V., Gritsan A.I., Eremenko A.A., et al. The efficacy and safety of dexmedetomidine for sedation of patients during prolonged mechanical ventilation in intensive care units (Russian multicenter study results). Anesteziologia i reanimatologia. 2015; 60(5): 47–53. (In Russ)]
  26. Линев Д.В., Ярошецкий А.И., Проценко Д.Н., Гельфанд Б.Р. Эффективность и безопасность дексмедетомидина, галоперидола и диазепама в лечении делирия: сравнительное исследование. Анестезиология и реаниматология. 2017; 62(6): 442–448. DOI: 10.18821/0201-7563-2017-62-6-442-448. [Linev D.V., Yaroshetskiy A.I., Protsenko D.N., Gel’fand B.R. The efficacy and the safety of dexmedetomidine, haloperidol and diazepam for treatment of delirium: a comparative study. Anesteziologiya i reanimatologiya (Russian Journal of Anaesthesiology and Reanimatology). 2017; 62(6): 442–448. (In Russ)]
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.